OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME
Zuzana Honetschlägerová, Kento Kitada, Zuzana Husková, et al.
Journal of Hypertension (2012) Vol. 31, Iss. 2, pp. 321-332
Open Access | Times Cited: 19
Zuzana Honetschlägerová, Kento Kitada, Zuzana Husková, et al.
Journal of Hypertension (2012) Vol. 31, Iss. 2, pp. 321-332
Open Access | Times Cited: 19
Showing 19 citing articles:
Flaxseed Consumption Reduces Blood Pressure in Patients With Hypertension by Altering Circulating Oxylipins via an α-Linolenic Acid–Induced Inhibition of Soluble Epoxide Hydrolase
Stephanie P. B. Caligiuri, Harold M. Aukema, Amir Ravandi, et al.
Hypertension (2014) Vol. 64, Iss. 1, pp. 53-59
Open Access | Times Cited: 126
Stephanie P. B. Caligiuri, Harold M. Aukema, Amir Ravandi, et al.
Hypertension (2014) Vol. 64, Iss. 1, pp. 53-59
Open Access | Times Cited: 126
The role of epoxyeicosatrienoic acids in the cardiovascular system
Lucy Yang, Kaisa Mäki-Petäjä, Joseph Cheriyan, et al.
British Journal of Clinical Pharmacology (2015) Vol. 80, Iss. 1, pp. 28-44
Open Access | Times Cited: 72
Lucy Yang, Kaisa Mäki-Petäjä, Joseph Cheriyan, et al.
British Journal of Clinical Pharmacology (2015) Vol. 80, Iss. 1, pp. 28-44
Open Access | Times Cited: 72
Intrapulmonary Activation of the Angiotensin-Converting Enzyme Type 2/Angiotensin 1-7/G-Protein-Coupled Mas Receptor Axis Attenuates Pulmonary Hypertension in Ren-2 Transgenic Rats Exposed to Chronic Hypoxia
Václav Hampl, Jan Herget, Jana Bı́bová, et al.
Physiological Research (2015), pp. 25-38
Open Access | Times Cited: 67
Václav Hampl, Jan Herget, Jana Bı́bová, et al.
Physiological Research (2015), pp. 25-38
Open Access | Times Cited: 67
Molecular role of cytochrome P4501A enzymes in oxidative stress
Rachel Stading, Chun Chu, Xanthi I. Couroucli, et al.
Current Opinion in Toxicology (2020) Vol. 20-21, pp. 77-84
Open Access | Times Cited: 54
Rachel Stading, Chun Chu, Xanthi I. Couroucli, et al.
Current Opinion in Toxicology (2020) Vol. 20-21, pp. 77-84
Open Access | Times Cited: 54
Epoxyeicosanoids in Hypertension
John D. Imig
Physiological Research (2019), pp. 695-704
Open Access | Times Cited: 47
John D. Imig
Physiological Research (2019), pp. 695-704
Open Access | Times Cited: 47
Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in R en‐2 transgenic hypertensive rats with aorto‐caval fistula
Luděk Červenka, Vojtěch Melenovský, Zuzana Husková, et al.
Clinical and Experimental Pharmacology and Physiology (2015) Vol. 42, Iss. 7, pp. 795-807
Closed Access | Times Cited: 42
Luděk Červenka, Vojtěch Melenovský, Zuzana Husková, et al.
Clinical and Experimental Pharmacology and Physiology (2015) Vol. 42, Iss. 7, pp. 795-807
Closed Access | Times Cited: 42
Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren‐2 transgenic hypertensive rats
Petr Kujal, Věra Čertíková Chábová, Petra Škaroupková, et al.
Clinical and Experimental Pharmacology and Physiology (2014) Vol. 41, Iss. 3, pp. 227-237
Open Access | Times Cited: 38
Petr Kujal, Věra Čertíková Chábová, Petra Škaroupková, et al.
Clinical and Experimental Pharmacology and Physiology (2014) Vol. 41, Iss. 3, pp. 227-237
Open Access | Times Cited: 38
The treatment with soluble guanylate cyclase stimulator BAY41-8543 prevents malignant hypertension and associated organ damage
Martina Hüttl, Matúš Miklovič, Olga Gawryś, et al.
Journal of Hypertension (2025)
Closed Access
Martina Hüttl, Matúš Miklovič, Olga Gawryś, et al.
Journal of Hypertension (2025)
Closed Access
Addition of ETA receptor blockade increases renoprotection provided by renin–angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats
Věra Čertíková Chábová, Zdeňka Vernerová, Petr Kujal, et al.
Life Sciences (2013) Vol. 118, Iss. 2, pp. 297-305
Open Access | Times Cited: 26
Věra Čertíková Chábová, Zdeňka Vernerová, Petr Kujal, et al.
Life Sciences (2013) Vol. 118, Iss. 2, pp. 297-305
Open Access | Times Cited: 26
Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis
Wensheng Deng, Yiming Zhu, Jiayun Lin, et al.
Prostaglandins & Other Lipid Mediators (2017) Vol. 131, pp. 67-74
Closed Access | Times Cited: 23
Wensheng Deng, Yiming Zhu, Jiayun Lin, et al.
Prostaglandins & Other Lipid Mediators (2017) Vol. 131, pp. 67-74
Closed Access | Times Cited: 23
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established
Šárka Jíchová, Libor Kopkan, Zuzana Husková, et al.
Journal of Hypertension (2016) Vol. 34, Iss. 10, pp. 2008-2025
Open Access | Times Cited: 22
Šárka Jíchová, Libor Kopkan, Zuzana Husková, et al.
Journal of Hypertension (2016) Vol. 34, Iss. 10, pp. 2008-2025
Open Access | Times Cited: 22
Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: Studies in Cyp1a1-Ren-2 transgenic rats
Alexandra Sporková, Šárka Jíchová, Zuzana Husková, et al.
Clinical and Experimental Pharmacology and Physiology (2014) Vol. 41, Iss. 12, pp. 1003-1013
Open Access | Times Cited: 21
Alexandra Sporková, Šárka Jíchová, Zuzana Husková, et al.
Clinical and Experimental Pharmacology and Physiology (2014) Vol. 41, Iss. 12, pp. 1003-1013
Open Access | Times Cited: 21
Fenofibrate Attenuates Malignant Hypertension by Suppression of the Renin-angiotensin System: A Study in Cyp1a1-Ren-2 Transgenic Rats
Šárka Jíchová, Šárka Doleželová, Libor Kopkan, et al.
The American Journal of the Medical Sciences (2016) Vol. 352, Iss. 6, pp. 618-630
Closed Access | Times Cited: 19
Šárka Jíchová, Šárka Doleželová, Libor Kopkan, et al.
The American Journal of the Medical Sciences (2016) Vol. 352, Iss. 6, pp. 618-630
Closed Access | Times Cited: 19
Morin induces endothelium-dependent relaxation by activating TRPV4 channels in rat mesenteric arteries
Xiao-Dong Zhang, Aiqin Mao, Wang Xiao, et al.
European Journal of Pharmacology (2019) Vol. 859, pp. 172561-172561
Closed Access | Times Cited: 15
Xiao-Dong Zhang, Aiqin Mao, Wang Xiao, et al.
European Journal of Pharmacology (2019) Vol. 859, pp. 172561-172561
Closed Access | Times Cited: 15
Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats
Petra Alánová, Zuzana Husková, Libor Kopkan, et al.
Vascular Pharmacology (2015) Vol. 73, pp. 45-56
Closed Access | Times Cited: 14
Petra Alánová, Zuzana Husková, Libor Kopkan, et al.
Vascular Pharmacology (2015) Vol. 73, pp. 45-56
Closed Access | Times Cited: 14
Early antihypertensive treatment and ischemia-induced acute kidney injury
Robert Greite, Katja Derlin, Bennet Hensen, et al.
AJP Renal Physiology (2020) Vol. 319, Iss. 4, pp. F563-F570
Open Access | Times Cited: 11
Robert Greite, Katja Derlin, Bennet Hensen, et al.
AJP Renal Physiology (2020) Vol. 319, Iss. 4, pp. F563-F570
Open Access | Times Cited: 11
Screening of soluble epoxide hydrolase inhibitory ingredients from traditional Chinese medicines for anti-inflammatory use
Jun‐Yan Liu, Christophe Morisseau, Huazhang Huang, et al.
Journal of Ethnopharmacology (2016) Vol. 194, pp. 475-482
Open Access | Times Cited: 10
Jun‐Yan Liu, Christophe Morisseau, Huazhang Huang, et al.
Journal of Ethnopharmacology (2016) Vol. 194, pp. 475-482
Open Access | Times Cited: 10
Impaired renal autoregulation and pressure-natriuresis: any role in the development of heart failure in normotensive and angiotensin II-dependent hypertensive rats?
Zuzana Honetschlägerová, Janusz Sadowski, Elżbieta Kompanowska‐Jezierska, et al.
Hypertension Research (2023) Vol. 46, Iss. 10, pp. 2340-2355
Open Access | Times Cited: 3
Zuzana Honetschlägerová, Janusz Sadowski, Elżbieta Kompanowska‐Jezierska, et al.
Hypertension Research (2023) Vol. 46, Iss. 10, pp. 2340-2355
Open Access | Times Cited: 3
Mechanism of Chronic Kidney Disease Progression and Novel Biomarkers: A Metabolomic Analysis of Experimental Glomerulonephritis
Kyoung Hee Han, Bora Kim, Sang Chun Ji, et al.
Metabolites (2020) Vol. 10, Iss. 4, pp. 169-169
Open Access | Times Cited: 8
Kyoung Hee Han, Bora Kim, Sang Chun Ji, et al.
Metabolites (2020) Vol. 10, Iss. 4, pp. 169-169
Open Access | Times Cited: 8
